Report cover image

Bioinformatics Market (Platforms, Tools, and Services: Platforms [Sequence Manipulation Platforms, Sequence Alignment Platforms, Structural Analysis Platforms, and Sequence Analysis Platforms], Tools [General Knowledge Management Tools and Specialized Kno

Publisher Transparency Market Research Pvt. Ltd.
Published Feb 14, 2022
Length 88 Pages
SKU # TNPR17067639

Description

Bioinformatics Market (Platforms, Tools, and Services: Platforms [Sequence Manipulation Platforms, Sequence Alignment Platforms, Structural Analysis Platforms, and Sequence Analysis Platforms], Tools [General Knowledge Management Tools and Specialized Knowledge Management Tools], and Services [Data Analysis, Sequencing Services, Database & Management, and Other Services]; and Application: Preventive Medicine, Molecular Medicine, Gene Therapy, Drug Development, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Bioinformatics Market – Scope of Report
TMR’s report on the global bioinformatics market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global bioinformatics market for the period 2017–2028, considering 2020 as the base year and 2021 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global bioinformatics market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global bioinformatics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global bioinformatics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global bioinformatics market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global bioinformatics market.

The report delves into the competitive landscape of the global bioinformatics market. Key players operating in the global bioinformatics market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global bioinformatics market that have been profiled in this report.

Key Questions Answered in Bioinformatics Market Report
What is the scope of growth of product companies in the global bioinformatics market?
What will be the Y-o-Y growth of the global bioinformatics market between 2017 and 2028?
What is the influence of changing trends in technologies on the global bioinformatics market?
Will North America be the most profitable market for bioinformatics product providers?
Which factors are anticipated to hamper the growth of the global bioinformatics market during the forecast period?
Which are the leading companies in the global bioinformatics market?
Research Methodology
TMR has utilized a unique research methodology to conduct comprehensive research on the growth of the global bioinformatics market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global bioinformatics market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the bioinformatics market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the bioinformatics market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global bioinformatics market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global bioinformatics market more reliably and accurately.

Companies Mentioned

Accelrys, Inc.
ID Business Solutions, Ltd.
Affymetrix, Inc.
CLC bio A/S
Agilent Technologies, Inc.
Life Technologies Corporation
Illumina, Inc.
Other prominent players

Table of Contents

88 Pages
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Bioinformatics Market
4. Market Overview
4.1. Introduction
4.1.1. Platforms, Tools, and Services Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Bioinformatics Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Software Analysis
5.2. Technological Advancements
5.3. Key Mergers, Acquisitions, Software launches
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Bioinformatics Market Analysis and Forecast, by Platforms, Tools, and Services
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Platforms, Tools, and Services, 2017–2031
6.3.1. Platforms
6.3.1.1. Sequence Manipulation Platforms
6.3.1.2. Sequence Alignment Platforms
6.3.1.3. Structural Analysis Platforms
6.3.1.4. Sequence Analysis Platforms
6.3.2. Tools
6.3.2.1. General Knowledge Management Tools
6.3.2.2. Specialized Knowledge Management Tools
6.3.3. Services
6.3.3.1. Data Analysis
6.3.3.2. Sequencing Services
6.3.3.3. Database & Management
6.3.3.4. Other services
6.4. Market Attractiveness Analysis, by Platforms, Tools, and Services
7. Global Bioinformatics Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Preventive Medicine
7.3.2. Molecular Medicine
7.3.3. Gene Therapy
7.3.4. Drug Development
7.3.5. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Bioinformatics Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Country/Region
9. North America Bioinformatics Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Platforms, Tools, and Services, 2017–2031
9.2.1. Platforms
9.2.1.1. Sequence Manipulation Platforms
9.2.1.2. Sequence Alignment Platforms
9.2.1.3. Structural Analysis Platforms
9.2.1.4. Sequence Analysis Platforms
9.2.2. Tools
9.2.2.1. General Knowledge Management Tools
9.2.2.2. Specialized Knowledge Management Tools
9.2.3. Services
9.2.3.1. Data Analysis
9.2.3.2. Sequencing Services
9.2.3.3. Database & Management
9.2.3.4. Other services
9.3. Market Value Forecast, by Application, 2017–2031
9.3.1. Preventive Medicine
9.3.2. Molecular Medicine
9.3.3. Gene Therapy
9.3.4. Drug Development
9.3.5. Others
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Platforms, Tools, and Services
9.5.2. By Application
9.5.3. By Country
10. Europe Bioinformatics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Platforms, Tools, and Services, 2017–2031
10.2.1. Platforms
10.2.1.1. Sequence Manipulation Platforms
10.2.1.2. Sequence Alignment Platforms
10.2.1.3. Structural Analysis Platforms
10.2.1.4. Sequence Analysis Platforms
10.2.2. Tools
10.2.2.1. General Knowledge Management Tools
10.2.2.2. Specialized Knowledge Management Tools
10.2.3. Services
10.2.3.1. Data Analysis
10.2.3.2. Sequencing Services
10.2.3.3. Database & Management
10.2.3.4. Other services
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Preventive Medicine
10.3.2. Molecular Medicine
10.3.3. Gene Therapy
10.3.4. Drug Development
10.3.5. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Platforms, Tools, and Services
10.5.2. By Application
10.5.3. By Country/Sub-region
11. Asia Pacific Bioinformatics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Platforms, Tools, and Services, 2017–2031
11.2.1. Platforms
11.2.1.1. Sequence Manipulation Platforms
11.2.1.2. Sequence Alignment Platforms
11.2.1.3. Structural Analysis Platforms
11.2.1.4. Sequence Analysis Platforms
11.2.2. Tools
11.2.2.1. General Knowledge Management Tools
11.2.2.2. Specialized Knowledge Management Tools
11.2.3. Services
11.2.3.1. Data Analysis
11.2.3.2. Sequencing Services
11.2.3.3. Database & Management
11.2.3.4. Other services
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Preventive Medicine
11.3.2. Molecular Medicine
11.3.3. Gene Therapy
11.3.4. Drug Development
11.3.5. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Platforms, Tools, and Services
11.5.2. By Application
11.5.3. By Country/Sub-region
12. Latin America Bioinformatics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Platforms, Tools, and Services, 2017–2031
12.2.1. Platforms
12.2.1.1. Sequence Manipulation Platforms
12.2.1.2. Sequence Alignment Platforms
12.2.1.3. Structural Analysis Platforms
12.2.1.4. Sequence Analysis Platforms
12.2.2. Tools
12.2.2.1. General Knowledge Management Tools
12.2.2.2. Specialized Knowledge Management Tools
12.2.3. Services
12.2.3.1. Data Analysis
12.2.3.2. Sequencing Services
12.2.3.3. Database & Management
12.2.3.4. Other services
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Preventive Medicine
12.3.2. Molecular Medicine
12.3.3. Gene Therapy
12.3.4. Drug Development
12.3.5. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Platforms, Tools, and Services
12.5.2. By Application
12.5.3. By Country/Sub-region
13. Middle East & Africa Bioinformatics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Platforms, Tools, and Services, 2017–2031
13.2.1. Platforms
13.2.1.1. Sequence Manipulation Platforms
13.2.1.2. Sequence Alignment Platforms
13.2.1.3. Structural Analysis Platforms
13.2.1.4. Sequence Analysis Platforms
13.2.2. Tools
13.2.2.1. General Knowledge Management Tools
13.2.2.2. Specialized Knowledge Management Tools
13.2.3. Services
13.2.3.1. Data Analysis
13.2.3.2. Sequencing Services
13.2.3.3. Database & Management
13.2.3.4. Other services
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Preventive Medicine
13.3.2. Molecular Medicine
13.3.3. Gene Therapy
13.3.4. Drug Development
13.3.5. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Platforms, Tools, and Services
13.5.2. By Application
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2020
14.3. Company Profiles
14.3.1. Accelrys, Inc.
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. ID Business Solutions, Ltd.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview
14.3.3. Affymetrix, Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. CLC bio A/S
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. Agilent Technologies, Inc.
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. Life Technologies Corporation
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Financial Overview
14.3.6.5. Strategic Overview
14.3.7. Illumina, Inc.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Financial Overview
14.3.7.5. Strategic Overview
14.3.8. Other prominent players
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Financial Overview
14.3.8.5. Strategic Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us